Qualigen Therapeutics Inc (QLGN) — Capital Reinvestment Ratio
Qualigen Therapeutics Inc (QLGN) has a Capital Reinvestment Ratio of 0.27x as of September 2023, meaning it reinvests 0% of its operating cash flow ($929.74K) in capital expenditures ($246.42K). See Qualigen Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qualigen Therapeutics Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Qualigen Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check QLGN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Qualigen Therapeutics Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Qualigen Therapeutics Inc from 2019 to 2019. For live market cap and broader valuation context, see Qualigen Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 3.39x | $57.33K | $194.48K | — |